PACS Group Provides Preliminary Third Quarter Operational Metrics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
JPMorgan Resumes PACS Group (PACS) at Overweight
November 6, 2024 6:20 AM ESTJPMorgan analyst Lisa Gill resumes coverage on PACS Group (NYSE: PACS) with a Overweight rating and a price target of $40.00.
The analyst comments "ollowing a period of restriction, we are moving to an OW rating for PACS Group and a December 2025 price target of $40 from a Not Rated designation. Consistent with our previous outlook (see our initiation from earlier this year here), we consider PACS as having an attractive business model focused on acquiring... More
